New hope for adult sufferers of most common primary brain tumor A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults. Results of a trial led by the university revealed that […]
Share This Story
Hispanics face nearly double the risk of developing Alzheimer’s disease compared to non-Hispanic whites, according to the National Institutes of Health National Institute on Aging.
Share This Story
Advancement in the detection and treatment of Alzheimer’s and other neurodegenerative diseases means more people can preserve brain health for longer. But a crisis looms as an onslaught of people at risk for neurodegenerative diseases in the next 40 years is met with a shortage of health care providers. According to the U.S. […]
Share This Story
In the coming years, Africa is expected to sustain the greatest increase in Alzheimer’s and related dementia cases. Advancing the ability of African scientists to conduct research in these fields is critical for progress in understanding and treating these conditions. A transformative training program crafted through a collaboration between the Glenn Biggs Institute for Alzheimer’s […]
Share This Story